Fans of wearable devices in more countries might start considering using the Samsung Galaxy Watch 3 or Watch Active 2 as their vital health monitoring features will be available soon. The tech company acquired the necessary permissions for its Health Monitor app to function in a total of 31 countries.
Samsung’s advanced health monitoring services cleared for use in more countries
The Samsung Galaxy Watch 3 and Watch Active 2 are equipped with sensors that allow them to monitor a user’s blood pressure and function with electrocardiogram (ECG) tracking. However, reading this data would require the Samsung Health Monitor app.
Like other health and medical products, the Samsung Health Monitor app needed to be approved in different countries following different regulations. It explains why tech features of this nature typically launch in limited territories. However, this changes for Samsung after the company acquired CE-marking last December for the software product allowing it to launch in European countries.
Samsung Galaxy Watch 3 and Watch Active 2 users Austria, Belgium, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, the Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Switzerland, and the United Kingdom will soon be able to use the said app for BP and ECG tracking. The app is also launching in Chile, Indonesia, and the UAE making it available in 31 countries after only being accessible in South Korea.
Once the Samsung Health Monitor app goes live in the said countries, Samsung Galaxy Watch 3 and Watch Active 2 have to be updated to their latest versions. Doing so will automatically install the app on the wearable devices. Updates can be initiated through the Galaxy Wearable app via a paired Galaxy smartphone.
Samsung Galaxy Watch 4 rumored to launch with blood sugar level sensor
Having a blood pressure and ECG monitor on people’s wrists through devices like Samsung Galaxy Watch 3 and Watch Active 2 is already a notable technological development. But the company is reportedly looking to add another essential medical tracker in its upcoming Galaxy Watch 4.
ET News reported that Samsung is planning to launch the Galaxy Watch 4 with blood sugar level tracking this year. It is expected to use optic sensors that would allow measure blood glucose levels without blood sampling.


Moonshot AI Executives Seek Settlement Ahead of Hong Kong IPO
Meta Launches Muse Wonder AI Models, Shares Rise 3.7%
New York Times, AFP Join Coalition to Protect Content From AI
Zcash Plans Quantum-Resistant Security Upgrade for January
Trezor Cuts Reseller Network After Ledger Security Breach
Arm Shares Fall Over 3% After Qualcomm Wins License Dispute
TSMC Profit Set to Surge 65% as AI Chip Demand Drives Record Earnings
Apple Supplier Luxshare Sees Limited Impact From US Patent Probe
Robinhood Chain Eyes Priority Gas Auctions for Faster Trades
AT&T Sells Mexico Wireless Business to Televisa for $2 Billion
OpenAI Revenue Hits $50 Billion, Below Earlier $70 Billion Estimate
Yandex Data Center Hit by Drone Strike as Russia-Ukraine Cyber Infrastructure Attacks Escalate
Arthur Hayes Announces FLOP Testnet Launch Within Weeks
Citi Upgrades Galaxy Digital Stock, Raises Price Target to $28
Arm Breaches Qualcomm License Deal, Jury Awards $2
Epic Games Delays Disney Shooter, Shifts to AI-First Development 



